Krebs, Simone http://orcid.org/0000-0002-9909-4531
Mauguen, Audrey http://orcid.org/0000-0003-3236-6093
Yildirim, Onur
Hatzoglou, Vaios http://orcid.org/0000-0003-0252-0694
Francis, Jasmine H.
Schaff, Lauren R. http://orcid.org/0000-0002-4664-670X
Mellinghoff, Ingo K. http://orcid.org/0000-0002-4347-8149
Schöder, Heiko http://orcid.org/0000-0002-5170-4185
Grommes, Christian http://orcid.org/0000-0002-7485-0441
Funding for this research was provided by:
Pharmacyclics (N/A)
National Cancer Institute (P30 CA008748, K12 CA184746)
National Institutes of Health (P50 CA192937)
Leukemia and Lymphoma Society (N/A)
Article History
Received: 4 February 2021
Accepted: 25 April 2021
First Online: 8 May 2021
Declarations
:
: All procedures involving human participants were performed in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed written consent was obtained from all individual participants included in the study.
: C.G. reports consulting for BTG International and Kite. The remaining authors have no competing interests.